Diabetes Mellitus: Pharmacological Innovations and Related Therapeutic Benefits
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 798
Special Issue Editor
Interests: type 2 diabetes; obesity; insulin resistance; metabolic syndrome; cardiovascular risk in metabolic diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Modern medical care for people with diabetes mellitus has some distinctive features. First, despite all preventive measures, we have witnessed an accelerated increase in the prevalence of diabetes worldwide; the most recent global estimates suggest that approximately 537 million people have diabetes and that there were 6.7 million diabetes-related deaths in 2021, with this number projected to increase to 783 million in adults by 2045 and 1.31 billion all-age people by 2050. Secondly, there have been extraordinary advancements in diabetes-targeting therapies in recent years, with multiple new therapeutic classes and novel technologies being developed to modify the clinical outcomes of people with diabetes. These innovations have fundamentally changed clinical guidelines, and the pace of development is so swift that medical thinking today has almost completely changed compared to only fifteen or twenty years ago. The fundamentals of diabetes care currently extend well beyond glucose control to weight control, encompass a multifactorial approach to cardiovascular risk, and promote the use of antihyperglycemic medications that also offer cardiorenal benefits. Together with the ever-present need to empower patients to successfully self-manage their disease, all these approaches will hopefully change the quality of life and disease duration for millions of people worldwide. Therefore, this Special Issue focuses on these significant advancements, starting from the first phases of pharmacological research on diabetes and extending to the various benefits we see developing regarding the clinical outcomes of people with diabetes.
Dr. Cristina-Mihaela Lăcătuşu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- therapy of diabetes mellitus
- pharmacological innovations
- incretins
- GLP-1 receptor agonists
- SGLT-2 inhibitors
- weight control
- diabetes-related cardiovascular risk
- non-glycemic benefits of diabetes drugs
- diabetes-related technologies
- diabetes outcomes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
